The impact of ex vivo lung perfusion location on lung transplant outcomes
Artificial Organs · 2024
DOI: 10.1111/aor.14829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2024. Verfasst von Doug A Gouchoe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Perfusion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Ex vivo lung perfusion (EVLP) conducted outside of the transplant center has increased in recent years to mitigate its limitation by resources and expertise. We sought to evaluate EVLP performed at transplant centers and externally.
Methods
Lung transplant recipients were identified from the United Network for Organ Sharing Database. Recipients were then stratified into two groups based where they were perfused: Transplant Program (TP) or External Perfusion Centers (EPC). The groups were assessed with comparative statistics and long‐term survival was assessed by Kaplan–Meier method. The groups were then 1:1 propensity and this process was repeated.
Results
EPC use was generally restricted to the Southern United States. Following matching, there were no significant differences in post‐operative outcomes to include post‐operative stroke, dialysis, airway dehiscence, ECMO use, ventilator use or incidence of primary graft dysfunction Grade 3. Adjusted 3‐year survival was 68.9% (95% Confidence Interval [CI]: 60.9%–77.9%) for the TP group and 67.6% (95% CI: 61.0%–74.9%) for the EPC group ( p = 0.69). In allografts with extended ischemia (14+ h), those in the TP group had significantly longer length of stay, prolonged ventilation and treated rejection in the 1st year, though no significant difference in mid‐term survival ( p = 0.66).
Conclusion
EVLP performed at an EPC can be carried out with results and survival similar to allografts undergoing EVLP at a TP. EPCs will extend the valuable resource of EVLP to lung transplant programs without the resources to perform EVLP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
- COPPER Laboratory, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
ORCID-Profile: Doug A Gouchoe, Matthew C Henn, Asvin M Ganapathi
Förderung
- NHLBI NIH HHS
Zitieren
APA
Gouchoe, D. A., Satija, D., Cui, E. Y., Ferrari-Light, D., Henn, M. C., Choi, K., Mokadam, N. A., Ganapathi, A. M., & Whitson, B. A. (2024). The impact of ex vivo lung perfusion location on lung transplant outcomes. Artificial Organs. https://doi.org/10.1111/aor.14829
Vancouver
Gouchoe DA, Satija D, Cui EY, Ferrari-Light D, Henn MC, Choi K, et al. The impact of ex vivo lung perfusion location on lung transplant outcomes. Artificial Organs. 2024. doi:10.1111/aor.14829
BibTeX
@article{Gouchoe2024,
author = {Gouchoe, Doug A and Satija, Divyaam and Cui, Ervin Y and Ferrari-Light, Dana and Henn, Matthew C and Choi, Kukbin and Mokadam, Nahush A and Ganapathi, Asvin M and Whitson, Bryan A},
title = {The impact of ex vivo lung perfusion location on lung transplant outcomes},
journal = {Artificial Organs},
year = {2024},
doi = {10.1111/aor.14829}
}
EUVIMED